chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccines were administrated beyond use date after the thaw process; This spontaneous case was reported by a paramedic and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccines were administrated beyond use date after the thaw process) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 29-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 29-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccines were administrated beyond use date after the thaw process). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccines were administrated beyond use date after the thaw process) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient age was reported as 20 years and 1 months.  No concomitant medication was provided.  It was reported that there was no patient that had any adverse reactions and no reports of any reactions after the administration of the vaccines.  No treatment medication was provided.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was administered after the beyond use date after the thaw process; This spontaneous case was reported by an HCP and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was administered after the beyond use date after the thaw process) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 28-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 28-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was administered after the beyond use date after the thaw process). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was administered after the beyond use date after the thaw process) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was reported.  The patient did not report any adverse reactions after the administration of vaccine.  Vaccine number 1 NDC code was reported as 80777-0273-99.   This case was linked to MOD-2022-542869 (Patient Link).
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Underdose
Clinical narrative: Second dose received 0.25ml instead of 0.5ml; Vaccines that were administered beyond use date after thaw process; This spontaneous case was reported by an HCP and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process) and UNDERDOSE (Second dose received 0.25ml instead of 0.5ml) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Dec-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 27-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process). On an unknown date, the patient experienced UNDERDOSE (Second dose received 0.25ml instead of 0.5ml). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process) and UNDERDOSE (Second dose received 0.25ml instead of 0.5ml) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient age was reported as 38 years and 1 month. No concomitant medication information was provided. On 10-Jun-2022, medical was notified about an audit that was done and they were then made aware of vaccines that were administered beyond use date after the thaw process.  Reporter stated that there was no patient that had any adverse reactions and there were no reports of any reactions after the administration of vaccines.  Vaccine NDC code was reported as 80777-0273-99. No treatment medication was provided.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccines that were administered beyond use date after thaw process; This spontaneous case was reported by a paramedic and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 29-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 29-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient age was reported as 20 years 1 month. No concomitant drug reported. It was reported that vaccine administrated beyond use date after the thaw process. There was no patient that had any adverse reactions and no reports of any reactions after the administration of the vaccines. No treatment information was provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site papule
Clinical narrative: I got some light red bumps on my arm about 3 hours after getting the 1st Moderna booster.; I got some light red bumps on my arm about 3 hours after getting the 1st Moderna booster.; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE ERYTHEMA (I got some light red bumps on my arm about 3 hours after getting the 1st Moderna booster.) and VACCINATION SITE PAPULE (I got some light red bumps on my arm about 3 hours after getting the 1st Moderna booster.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (I got some light red bumps on my arm about 3 hours after getting the 1st Moderna booster.) and VACCINATION SITE PAPULE (I got some light red bumps on my arm about 3 hours after getting the 1st Moderna booster.). At the time of the report, VACCINATION SITE ERYTHEMA (I got some light red bumps on my arm about 3 hours after getting the 1st Moderna booster.) and VACCINATION SITE PAPULE (I got some light red bumps on my arm about 3 hours after getting the 1st Moderna booster.) had resolved. Not Provided          No relevant concomitant medications were reported.   The patient tolerated the first two Moderna shots well, got some light red bumps on arm about 3 hours after getting the 1st Moderna booster. Those were not painful, and they went away 1-2 days later.  No treatment information was provided.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Patient received dose from a vial which was initially stored in the refrigerator and administered to patient after 30-day Use By Date; The patient administered the vaccine after the 30 days beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT STORAGE ERROR (Patient received dose from a vial which was initially stored in the refrigerator and administered to patient after 30-day Use By Date) and EXPIRED PRODUCT ADMINISTERED (The patient administered the vaccine after the 30 days beyond use date) in a 43-year-old female patient who received mRNA-1273 (Spikevax) (batch nos. 027L21A and 33K212A) for COVID-19 prophylaxis.     Patient had not been diagnosed with/tested positive for COVID-19.    On 28-Apr-2022 at 11:00 AM, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 27-May-2022 at 3:00 PM, received second dose of mRNA-1273 (Spikevax) (Intramuscular) dosage was changed to .5 milliliter. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient administered the vaccine after the 30 days beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received dose from a vial which was initially stored in the refrigerator and administered to patient after 30-day Use By Date). At the time of the report, PRODUCT STORAGE ERROR (Patient received dose from a vial which was initially stored in the refrigerator and administered to patient after 30-day Use By Date) and EXPIRED PRODUCT ADMINISTERED (The patient administered the vaccine after the 30 days beyond use date) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Six vials of lot number 027L21A was initially stored in the refrigerator on 08-Mar-2022. 10 vials of lot number 33K212Awas initially stored in the refrigerator on 28-Feb-2022.The vials did not undergo any temperature excursions.  It was unknown if the patient had any prescriptions, over the counter medication, dietary supplements or herbal remedies taken at the time of vaccination   The patients had not reported symptoms.   No additional doses, medications or treatments had been administered.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccines that were administered beyond use date after thaw process; This spontaneous case was reported by a paramedic and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 prophylaxis.     It was unknown if patient had been diagnosed with or tested positive for COVID-19, nor if patient had chronic or long lasting health conditions. It was unknown if patient had any acute illness at the time of vaccination and up to one month before.     On 30-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 30-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient age was reported as 68 years and 8 months.  No concomitant medications were reported.  On 10-Jun-2022, the vaccination facility was made aware of administration of vaccines beyond use date after the thaw process while audit was conducted. Patient got Moderna with vaccine Ndc code 80777-0273-99.  Patient had reported no adverse reactions after the administration of vaccine.  No treatment medication were reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was administered beyond use date after the thaw process; This spontaneous case was reported by an HCP and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was administered beyond use date after the thaw process) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 30-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 30-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was administered beyond use date after the thaw process). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was administered beyond use date after the thaw process) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient's age was reported as 72 years 5 months.  No concomitant medications were provided by the reporter.  It was reported that vaccines were administered beyond use date after the thaw process. There was no patient that had any adverse reactions and no reports of any reactions after the administration of the vaccines.  No treatment medications were provided by the reporter.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine administrated beyond use date after the thaw process; This spontaneous case was reported by an HCP and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine administrated beyond use date after the thaw process) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029H21B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 20-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 20-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine administrated beyond use date after the thaw process). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine administrated beyond use date after the thaw process) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient age was reported as 35 years 3 months.  No concomitant drug reported.  It was reported vaccine administrated beyond use date after the thaw process. There was no patient that had any adverse reactions and no reports of any reactions after the administration of the vaccines.  No treatment information was provided by the reporter.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccines that were administered beyond use date after thaw process; This spontaneous case was reported by an HCP and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029H21B) for COVID-19 prophylaxis.     It was unknown if patient had ever diagnosed positive with Covid-19.  It was unknown if patient had any acute illness at the time of vaccination or up to one month before. It was unknown if patient had any chronic or long-standing health conditions.     On 19-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 19-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient age was reported as 31 years 10 months. No concomitant drug reported. It was reported vaccine administrated beyond use date after the thaw process. There was no patient that had any adverse reactions and no reports of any reactions after the administration of the vaccines. No treatment information was provided by the reporter.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccines that were administered beyond use date after thaw process; This spontaneous case was reported by an HCP and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029H21B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 17-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 17-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient age was reported as 29 years and 09 months. No concomitant medications were reported.  It was reported that the vaccines were administered beyond use date after the thaw process. Patient had not reported any adverse reactions after the administration of the vaccine.  No treatment medications were reported.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccines that were administered beyond use date after thaw process; This spontaneous case was reported by an HCP and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029H21B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 20-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 20-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications was reported.  It was unknown if the patient was tested positive or diagnosed with COVID-19. It was unknown if acute illnesses at the time of vaccination and up to one month before. And it was unknown if chronic or long-standing health conditions.  The vaccine was used beyond use date of some lot numbers for Moderna that were administered to patients. There was no adverse reaction noted or reported to the reporter ever regarding after administration of vaccine.  No treatment drug details was reported.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: POTENTIAL SUBPOTENT DOSE
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: POTENTIAL SUBPOTENT DOSE
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: POTENTIAL SUBPOTENT DOSE
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: POTENTIAL SUBPOTENT DOSE
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID BREAKTHROUGH CASE
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: POTENTIAL SUBPOTENT DOSE
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: POTENTIAL SUBPOTENT DOSE
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: POTENTIAL SUBPOTENT DOSE
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID BREAKTHROUGH CASE
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: POTENTIAL SUBPOTENT DOSE
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Client stated that she had a temp of 99.4 max on Saturday 6/25/22.   Rash on chest and injection arm developed on Sunday 6/26/22
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: POTENTIAL SUBPOTENT DOSE
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: admission of covid positive pt fully vaccinated
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID BREAKTHROUGH CASE
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: POTENTIAL SUBPOTENT DOSE
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hypophagia, Malaise, Unresponsive to stimuli
Clinical narrative: 6/23/22 Received vaccine 6/24/22 Seen by NP with c/o not feeling well. Fatigue and not eating but drinking appropriately. 6/27/22 Found unresponsive in room.
Age: 4.0
Sex: F
Vaccine: TDAP
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Tdap was given instead of Dtap by accident. Patient did not have any adverse reaction.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Cold sweat, Dizziness, Feeling cold, Vision blurred
Clinical narrative: Approximately 10 minutes post vaccination patient complained of feeling light headed, patient felt clamy and cold. Pt also complained of blurry vision and dizziness . BP taken 80/52 leaft arm sitting HR 92. Unable to obtain O2 sat at that time. Medical triage called.
Age: 93.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID BREAKTHROUGH CASE
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Product measured potency issue
Clinical narrative: POTENTIAL SUBPOTENT DOSE
Age: 86.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Arthralgia, Atrioventricular block first degree, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal
Clinical narrative: Discharge Provider: Private MD Primary Care Provider at Discharge: Private MD  Admission Date: 6/20/2022 Discharge Date: 6/24/2022  PRESENTING PROBLEM: Hyponatremia [E87.1] Hip pain [M25.559] Fever, unspecified fever cause [R50.9] Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE: Patient is a 87 y.o. female who presented to the emergency department with complaints of fever.  She has a past medical history of asthma, CVA, glaucoma, and memory impairment. Per report from the patient's son, patient has been increasingly confused over the past week.  He states that today, she has become increasingly lethargic and not performing daily activities as usual.  She ate breakfast, however, she refused lunch and dinner. She was sent to the emergency department for further evaluation when it was noted by staff that she had a temperature of approximately 101.4° F. in the emergency department, patient was tachypneic, however, other vital signs were stable.  She did not require supplemental oxygen.  Complete blood count was unremarkable.  CMP was remarkable for hyponatremia.  Troponin was negative.  Procalcitonin was negative.  COVID-19 was positive.  EKG showed sinus rhythm with a first-degree AV block.  Chest x-ray showed findings consistent with COVID-19 pneumonia.  Suspect presenting symptoms are secondary to COVID-19 pneumonia.  Patient has been admitted for further evaluation and management of COVID-19 pneumonia and hyponatremia.     6/24:  Patient did very well during this admission.  Her hyponatremia has improved, it was felt to be in part due to hypovolemia.  I will start her on salt tablets 2 times a day as well.  Patient also was diagnosed with COVID, but steroids were stopped, she did not show any obvious respiratory involvement.  Patient was seen by Physical therapy and has slowly improved, she will go back to the "Private".  Patient will follow-up with Ophthalmology regarding a Pterygium. Patient is otherwise stable for discharge. She will need a repeat BMP on Monday June 27th.
Age: 86.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Confusional state, Diet refusal, Electrocardiogram abnormal, Full blood count normal, Hyponatraemia
Clinical narrative: Discharge Provider: Private MD Primary Care Provider at Discharge: Private MD  Admission Date: 6/20/2022 Discharge Date: 6/24/2022  PRESENTING PROBLEM: Hyponatremia [E87.1] Hip pain [M25.559] Fever, unspecified fever cause [R50.9] Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE: Patient is a 87 y.o. female who presented to the emergency department with complaints of fever.  She has a past medical history of asthma, CVA, glaucoma, and memory impairment. Per report from the patient's son, patient has been increasingly confused over the past week.  He states that today, she has become increasingly lethargic and not performing daily activities as usual.  She ate breakfast, however, she refused lunch and dinner. She was sent to the emergency department for further evaluation when it was noted by staff that she had a temperature of approximately 101.4° F. in the emergency department, patient was tachypneic, however, other vital signs were stable.  She did not require supplemental oxygen.  Complete blood count was unremarkable.  CMP was remarkable for hyponatremia.  Troponin was negative.  Procalcitonin was negative.  COVID-19 was positive.  EKG showed sinus rhythm with a first-degree AV block.  Chest x-ray showed findings consistent with COVID-19 pneumonia.  Suspect presenting symptoms are secondary to COVID-19 pneumonia.  Patient has been admitted for further evaluation and management of COVID-19 pneumonia and hyponatremia.     6/24:  Patient did very well during this admission.  Her hyponatremia has improved, it was felt to be in part due to hypovolemia.  I will start her on salt tablets 2 times a day as well.  Patient also was diagnosed with COVID, but steroids were stopped, she did not show any obvious respiratory involvement.  Patient was seen by Physical therapy and has slowly improved, she will go back to the "Private".  Patient will follow-up with Ophthalmology regarding a Pterygium. Patient is otherwise stable for discharge. She will need a repeat BMP on Monday June 27th.
Age: 86.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Hypophagia, Hypovolaemia, Lethargy, Loss of personal independence in daily activities, Metabolic function test
Clinical narrative: Discharge Provider: Private MD Primary Care Provider at Discharge: Private MD  Admission Date: 6/20/2022 Discharge Date: 6/24/2022  PRESENTING PROBLEM: Hyponatremia [E87.1] Hip pain [M25.559] Fever, unspecified fever cause [R50.9] Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE: Patient is a 87 y.o. female who presented to the emergency department with complaints of fever.  She has a past medical history of asthma, CVA, glaucoma, and memory impairment. Per report from the patient's son, patient has been increasingly confused over the past week.  He states that today, she has become increasingly lethargic and not performing daily activities as usual.  She ate breakfast, however, she refused lunch and dinner. She was sent to the emergency department for further evaluation when it was noted by staff that she had a temperature of approximately 101.4° F. in the emergency department, patient was tachypneic, however, other vital signs were stable.  She did not require supplemental oxygen.  Complete blood count was unremarkable.  CMP was remarkable for hyponatremia.  Troponin was negative.  Procalcitonin was negative.  COVID-19 was positive.  EKG showed sinus rhythm with a first-degree AV block.  Chest x-ray showed findings consistent with COVID-19 pneumonia.  Suspect presenting symptoms are secondary to COVID-19 pneumonia.  Patient has been admitted for further evaluation and management of COVID-19 pneumonia and hyponatremia.     6/24:  Patient did very well during this admission.  Her hyponatremia has improved, it was felt to be in part due to hypovolemia.  I will start her on salt tablets 2 times a day as well.  Patient also was diagnosed with COVID, but steroids were stopped, she did not show any obvious respiratory involvement.  Patient was seen by Physical therapy and has slowly improved, she will go back to the "Private".  Patient will follow-up with Ophthalmology regarding a Pterygium. Patient is otherwise stable for discharge. She will need a repeat BMP on Monday June 27th.
Age: 86.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Metabolic function test abnormal, Procalcitonin normal, Pterygium, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Discharge Provider: Private MD Primary Care Provider at Discharge: Private MD  Admission Date: 6/20/2022 Discharge Date: 6/24/2022  PRESENTING PROBLEM: Hyponatremia [E87.1] Hip pain [M25.559] Fever, unspecified fever cause [R50.9] Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE: Patient is a 87 y.o. female who presented to the emergency department with complaints of fever.  She has a past medical history of asthma, CVA, glaucoma, and memory impairment. Per report from the patient's son, patient has been increasingly confused over the past week.  He states that today, she has become increasingly lethargic and not performing daily activities as usual.  She ate breakfast, however, she refused lunch and dinner. She was sent to the emergency department for further evaluation when it was noted by staff that she had a temperature of approximately 101.4° F. in the emergency department, patient was tachypneic, however, other vital signs were stable.  She did not require supplemental oxygen.  Complete blood count was unremarkable.  CMP was remarkable for hyponatremia.  Troponin was negative.  Procalcitonin was negative.  COVID-19 was positive.  EKG showed sinus rhythm with a first-degree AV block.  Chest x-ray showed findings consistent with COVID-19 pneumonia.  Suspect presenting symptoms are secondary to COVID-19 pneumonia.  Patient has been admitted for further evaluation and management of COVID-19 pneumonia and hyponatremia.     6/24:  Patient did very well during this admission.  Her hyponatremia has improved, it was felt to be in part due to hypovolemia.  I will start her on salt tablets 2 times a day as well.  Patient also was diagnosed with COVID, but steroids were stopped, she did not show any obvious respiratory involvement.  Patient was seen by Physical therapy and has slowly improved, she will go back to the "Private".  Patient will follow-up with Ophthalmology regarding a Pterygium. Patient is otherwise stable for discharge. She will need a repeat BMP on Monday June 27th.
Age: 86.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Tachypnoea, Troponin normal
Clinical narrative: Discharge Provider: Private MD Primary Care Provider at Discharge: Private MD  Admission Date: 6/20/2022 Discharge Date: 6/24/2022  PRESENTING PROBLEM: Hyponatremia [E87.1] Hip pain [M25.559] Fever, unspecified fever cause [R50.9] Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE: Patient is a 87 y.o. female who presented to the emergency department with complaints of fever.  She has a past medical history of asthma, CVA, glaucoma, and memory impairment. Per report from the patient's son, patient has been increasingly confused over the past week.  He states that today, she has become increasingly lethargic and not performing daily activities as usual.  She ate breakfast, however, she refused lunch and dinner. She was sent to the emergency department for further evaluation when it was noted by staff that she had a temperature of approximately 101.4° F. in the emergency department, patient was tachypneic, however, other vital signs were stable.  She did not require supplemental oxygen.  Complete blood count was unremarkable.  CMP was remarkable for hyponatremia.  Troponin was negative.  Procalcitonin was negative.  COVID-19 was positive.  EKG showed sinus rhythm with a first-degree AV block.  Chest x-ray showed findings consistent with COVID-19 pneumonia.  Suspect presenting symptoms are secondary to COVID-19 pneumonia.  Patient has been admitted for further evaluation and management of COVID-19 pneumonia and hyponatremia.     6/24:  Patient did very well during this admission.  Her hyponatremia has improved, it was felt to be in part due to hypovolemia.  I will start her on salt tablets 2 times a day as well.  Patient also was diagnosed with COVID, but steroids were stopped, she did not show any obvious respiratory involvement.  Patient was seen by Physical therapy and has slowly improved, she will go back to the "Private".  Patient will follow-up with Ophthalmology regarding a Pterygium. Patient is otherwise stable for discharge. She will need a repeat BMP on Monday June 27th.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Product measured potency issue
Clinical narrative: POTENTIAL SUBPOTENT DOSE
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Tremor
Clinical narrative: Approximately 15 minutes post injection, patient complained of nausea, dizziness. Pt became very shaky BP 124/84 HR 123, RR 24 and O2 sat 97%. Pt took 2 salt tabs due to history of POTS, EMS called for evaluation. Pt taken to First Aid via stretcher for further evaluation.
Age: 3.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product administration error
Clinical narrative: Admin Error Occurred
Age: 3.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Product preparation issue
Clinical narrative: Admin Error Occurred
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Gait disturbance, Immediate post-injection reaction, Inflammation, Neck pain
Clinical narrative: Within 2 hours of receiving the COVID 19 shot (Pfizer) is immediately experience muscle cramping.      With the 2nd shot, I immediately began to experience pain in all of my major joints, shoulders, neck, hands, knees and feet.     This pain was so bad there were days I could barely walk.     I continue today having these joint problems in my hands, neck and feet (almost 7 months after my last vaccine)      I paid $2000 for therapy over the course of 3 months which relieved it somewhat, but I have not felt the same since being forced to get this vaccine.    My joint pain and inflammation in my body has exacerbated by this vaccine and it continues to this day.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity
Clinical narrative: Within 2 hours of receiving the COVID 19 shot (Pfizer) is immediately experience muscle cramping.      With the 2nd shot, I immediately began to experience pain in all of my major joints, shoulders, neck, hands, knees and feet.     This pain was so bad there were days I could barely walk.     I continue today having these joint problems in my hands, neck and feet (almost 7 months after my last vaccine)      I paid $2000 for therapy over the course of 3 months which relieved it somewhat, but I have not felt the same since being forced to get this vaccine.    My joint pain and inflammation in my body has exacerbated by this vaccine and it continues to this day.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Inflammation, Pain, Pain in extremity, Peripheral swelling
Clinical narrative: Arm was sore the first evening. The following day it was inflamed, very swollen, red/hot to touch, and ached with every movement. This continued, but on June 26th the swelling went down some. The 27thit has subsided, could sleep on that side for a while last night.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Skin warm, Sleep disorder
Clinical narrative: Arm was sore the first evening. The following day it was inflamed, very swollen, red/hot to touch, and ached with every movement. This continued, but on June 26th the swelling went down some. The 27thit has subsided, could sleep on that side for a while last night.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against and then tested positive for COVID19
Age: 3.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Administration error occurred.
Age: 84.0
Sex: U
Vaccine: UNK
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Pt admit to facility and tested positive for COVID.  Pt received COVID Vaccine.
Age: 11.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against and then tested positive for COVID19
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Patient developed COVID-19 after vaccinations given.
Age: 51.0
Sex: F
Vaccine: COVID19, PNC20
Symptoms: Angiogram cerebral abnormal, Arteriogram carotid, Brain death, Brain herniation, Cerebral haematoma
Clinical narrative: Patient received COVID booster and Pneumovax during PCP appointment on 6/13/22. Later that day, awoke from a nap with a bad headache. Took Tylenol, and the next day complained of bilateral jaw pain and told to continue tylenol. Increased headache by Saturday 6/18 and patient presented to ED.  While in the ED, she had a deterioration of neurologic status and a head CT was performed with results as below. Started on clevidipine infusion, received tranexamic acid, mannitol, hypertonic saline. Unable to received transfusions per religion. Repeat head CT showed increased size of hematoma and vasogenic edema, with worsening mass effect and midline shift, as well as herniation. Unable to perform surgical intervention due to thrombocytopenia. Herniation on 6/19 and transitioned to comfort measures, with brain death on 6/20/22.
Age: 51.0
Sex: F
Vaccine: COVID19, PNC20
Symptoms: Cerebral haemorrhage, Cerebral infarction, Cerebral mass effect, Computerised tomogram head abnormal, Headache
Clinical narrative: Patient received COVID booster and Pneumovax during PCP appointment on 6/13/22. Later that day, awoke from a nap with a bad headache. Took Tylenol, and the next day complained of bilateral jaw pain and told to continue tylenol. Increased headache by Saturday 6/18 and patient presented to ED.  While in the ED, she had a deterioration of neurologic status and a head CT was performed with results as below. Started on clevidipine infusion, received tranexamic acid, mannitol, hypertonic saline. Unable to received transfusions per religion. Repeat head CT showed increased size of hematoma and vasogenic edema, with worsening mass effect and midline shift, as well as herniation. Unable to perform surgical intervention due to thrombocytopenia. Herniation on 6/19 and transitioned to comfort measures, with brain death on 6/20/22.
Age: 51.0
Sex: F
Vaccine: COVID19, PNC20
Symptoms: Neurological decompensation, Pain in jaw, Platelet count decreased, Refusal of treatment by patient, Scan with contrast
Clinical narrative: Patient received COVID booster and Pneumovax during PCP appointment on 6/13/22. Later that day, awoke from a nap with a bad headache. Took Tylenol, and the next day complained of bilateral jaw pain and told to continue tylenol. Increased headache by Saturday 6/18 and patient presented to ED.  While in the ED, she had a deterioration of neurologic status and a head CT was performed with results as below. Started on clevidipine infusion, received tranexamic acid, mannitol, hypertonic saline. Unable to received transfusions per religion. Repeat head CT showed increased size of hematoma and vasogenic edema, with worsening mass effect and midline shift, as well as herniation. Unable to perform surgical intervention due to thrombocytopenia. Herniation on 6/19 and transitioned to comfort measures, with brain death on 6/20/22.
Age: 51.0
Sex: F
Vaccine: COVID19, PNC20
Symptoms: Thrombocytopenia, Vasogenic cerebral oedema
Clinical narrative: Patient received COVID booster and Pneumovax during PCP appointment on 6/13/22. Later that day, awoke from a nap with a bad headache. Took Tylenol, and the next day complained of bilateral jaw pain and told to continue tylenol. Increased headache by Saturday 6/18 and patient presented to ED.  While in the ED, she had a deterioration of neurologic status and a head CT was performed with results as below. Started on clevidipine infusion, received tranexamic acid, mannitol, hypertonic saline. Unable to received transfusions per religion. Repeat head CT showed increased size of hematoma and vasogenic edema, with worsening mass effect and midline shift, as well as herniation. Unable to perform surgical intervention due to thrombocytopenia. Herniation on 6/19 and transitioned to comfort measures, with brain death on 6/20/22.
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against and then tested positive for COVID19
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: Pt was hospitalized with covid on 6/10/22 and died on 6/25/22
Sex: U
Vaccine: UNK
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Admit to facility and tested positive for COVID.  Pt had COVID vaccine.
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Body temperature increased, Erythema, Flushing, Headache, Heart rate increased
Clinical narrative: After the shot at 430 pm, arm was sore that night. The next day, it was extremely sore and two inch round dark red area. I have a picture if can send, if that is possible.  About mid day extreme body aches. Headache, middle back kidney area. Mid afternoon prickly feeling, then red flushing on cheeks, jaw, neck and chest. Temperature, finally took it mid afternoon and it was near 102. Went to pharmacy clinic at 5 but they would not see me because they closed at 530 and would not see another patient. Pharmacist told me it would be ok to take two Benadryl. which I did at approximately 530. It relieved the flushing hives somewhat. That said, I had racing fast heart rate, and my oxygen was 88 to 92 all that evening. I had a pulse oxygen reader from when I had had covid in January 22, which is how I know the oxygen level was low.  Note, I would have gone to urgent care, but all Urgent Care facilities were closed on that Saturday evening!
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Oxygen saturation decreased, Pain, Pain in extremity, Paraesthesia, Renal pain
Clinical narrative: After the shot at 430 pm, arm was sore that night. The next day, it was extremely sore and two inch round dark red area. I have a picture if can send, if that is possible.  About mid day extreme body aches. Headache, middle back kidney area. Mid afternoon prickly feeling, then red flushing on cheeks, jaw, neck and chest. Temperature, finally took it mid afternoon and it was near 102. Went to pharmacy clinic at 5 but they would not see me because they closed at 530 and would not see another patient. Pharmacist told me it would be ok to take two Benadryl. which I did at approximately 530. It relieved the flushing hives somewhat. That said, I had racing fast heart rate, and my oxygen was 88 to 92 all that evening. I had a pulse oxygen reader from when I had had covid in January 22, which is how I know the oxygen level was low.  Note, I would have gone to urgent care, but all Urgent Care facilities were closed on that Saturday evening!
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Urticaria
Clinical narrative: After the shot at 430 pm, arm was sore that night. The next day, it was extremely sore and two inch round dark red area. I have a picture if can send, if that is possible.  About mid day extreme body aches. Headache, middle back kidney area. Mid afternoon prickly feeling, then red flushing on cheeks, jaw, neck and chest. Temperature, finally took it mid afternoon and it was near 102. Went to pharmacy clinic at 5 but they would not see me because they closed at 530 and would not see another patient. Pharmacist told me it would be ok to take two Benadryl. which I did at approximately 530. It relieved the flushing hives somewhat. That said, I had racing fast heart rate, and my oxygen was 88 to 92 all that evening. I had a pulse oxygen reader from when I had had covid in January 22, which is how I know the oxygen level was low.  Note, I would have gone to urgent care, but all Urgent Care facilities were closed on that Saturday evening!
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, Exposure to SARS-CoV-2, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough COVID infection on 6/23/2022. Tested due to reported exposure by friend. Asymptomatic.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Resident received COVID vaccinations.  No Lot number indiated.  He has since developed COVID-19.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Patient developed COVID-19 after all vaccinations given.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Patient developed COVID-19 after all immunizations given.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Feeling hot, Hyperhidrosis, Irritable bowel syndrome
Clinical narrative: It felt like I was having irritable bowel attack. I was sweating and I was panting and I was very very hot. They laid me down on the floor because it was cool. They gave me an EPI shot and some BENADRYL and I was then able to open my eyes.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Stored in freezer
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Patient didn't have any adverse events but received 0.3ml of the Pfizer covid 19 shot without dilution of the product.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Stored in freezer
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Stored in the freezer
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Sudden onset of paresthesia, knee to foot, bilaterally and no improvement after 4 weeks
Age: 94.0
Sex: U
Vaccine: UNK
Symptoms: COVID-19
Clinical narrative: Diagnosed with Covid.  Had Covid vaccine.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Arthralgia, Chills, Decreased appetite, Fatigue, Headache
Clinical narrative: After the 4th injection...2nd booster...chills, fever, headache, loss of appetite, severe joint pain, extreme fatigue
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: After the 4th injection...2nd booster...chills, fever, headache, loss of appetite, severe joint pain, extreme fatigue
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Stored in the freezer
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, COVID-19, Feeling abnormal, Headache, Influenza like illness
Clinical narrative: A few days ago, on 06/25. I started feeling a little bit off with a sore shoulder and neck. I assumed it may be due to a recent car accident I was in. But by the third day, in the afternoon, I began to feel flu like. I was sore and had a temperature of 100.5. I had a friend take me to a local urgent care clinic who did a Covid test which came back positive. They advised that I speak with my doctor about possibly receiving a monoclonal antibody infusion. I have a telehealth visit scheduled for today to determine if that is a good path of treatment for me. I continued to feel badly and run a slight fever through the night last night. Compared to yesterday, my symptoms have been less intense. My temperature seems lower and I'm not quite as sore as I was before but I did wake up with a pretty heavy duty headache. I took some TYLENOL extra strength which helped with the headache, but it did not completely go away.